Social Media Influencers Driving Unofficial Trade for Unapproved Slimming Medication

A shadow economy for unapproved slimming drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Investigational Treatment Gaining Traction Online

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to message these profiles privately for source information, while also receiving promotional offers.

Thriving Commerce on Social Networks

Additionally, a flourishing market exists on Telegram, where communities with thousands of members share comparison photos, injection guides and assertions of rapid UK delivery. Vendors market the substance there before directing buyers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist patients lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.

Healthcare Experts Express Concerns

However, doctors and pharmacists have warned that the sale of what remains an unapproved drug in the United Kingdom is a cause for concern and could lead to individuals administering substances of uncertain source.

Several experts said the popularity for retatrutide could be connected to the increasing cost of licensed slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still violate pharmaceutical, advertising, and consumer laws, risking fines, legal action or imprisonment.

Service Reaction and Content Elimination

Based on the social media company, the platform has taken down problematic material and prohibited related hashtags and query recommendations. The organization stated it was committed to maintaining the platform secure and investing in strengthening enforcement strategies.

Online Marketplace Activities

Research also found communities with up to 9,000 participants marketing retatrutide using the platform's built-in search feature, which operates like a public directory. Typing “retatrutide” instantly brings up channels with thousands of users, filled with images of slimming results, positive testimonials and detailed instructions for preparing or injecting at home.

After minutes of entering one group, a vendor shared WhatsApp details, where the majority of transactions take place. The vendor sent an instruction manual and guaranteed shipping within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about weight, health issues or past usage.

Product Information and Pricing

Within these communities, messages display black plastic parcels with postal service labels, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at residence with sterile water, or ready-to-use injectors usually sold at £160 for 20 milligrams. When questioned how much time a pen should be used, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for the messaging service stated it actively monitored harmful content on its service including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting materials they can’t verify. Even if the science behind this drug is valid, these online versions may not include what they advertise,” stated Jason Murphy, the head of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor connected the increase in demand to recent cost increases for approved slimming medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit injections are highly risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.

Her team has previously encountered patients harmed by self-injection from unverified suppliers. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company experimental product not yet approved … may expose patients to possibly significant health risks”.

John Townsend
John Townsend

A tech journalist and digital strategist with over a decade of experience covering emerging technologies and their impact on business and society.